Is there a relationship between clinical stage and cardiovascular disease risk in bipolar disorder?

被引：0
|
作者：
Altinbas, K. [1 ]
Sinanoglu, G. Kayak [1 ]
机构：
[1] Selcuk Univ, Psychiat, Konya, Turkey
来源：
EUROPEAN PSYCHIATRY | 2022年 / 65卷
关键词：
clinical stage; cardiovascular disease risk; q risk3; bipolar disorder;
D O I：
10.1192/j.eurpsy.2022.1033
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
EPV0081
引用
收藏
页码：S407 / S407
页数：1
相关论文
共 50 条
  • [21] Cardiovascular disease and metabolic risk factors in male patients with schizophrenia, Schizoaffective disorder, and bipolar disorder
    Kilbourne, Amy M.
    Brar, Jaspreet S.
    Drayer, Rebecca A.
    Xu, Xiangyan
    Post, Edward P.
    PSYCHOSOMATICS, 2007, 48 (05) : 412 - 417
  • [22] The relationship between neurotrophins and bipolar disorder
    Wu, Renrong
    Fan, Jinbo
    Zhao, Jingping
    Calabrese, Joseph R.
    Gao, Keming
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2014, 14 (01) : 51 - 65
  • [23] The relationship between bipolar disorder and personality
    Kopacz, DR
    Janicak, PG
    PSYCHIATRIC ANNALS, 1996, 26 (10) : 644 - 650
  • [24] Cardiovascular risk in patients with bipolar disorder in Tunisia
    Njah, D.
    Lagha, M.
    Boudriga, S.
    Homri, W.
    Ben Romdhane, I.
    Labbene, R.
    EUROPEAN PSYCHIATRY, 2023, 66 : S696 - S696
  • [25] Cardiovascular risk and physical activity in bipolar disorder
    Sylvia, L.
    Kuperberg, M.
    Amado, S.
    Rakhilin, M.
    Nierenberg, A.
    BIPOLAR DISORDERS, 2020, 22 : 26 - 27
  • [26] Cardiovascular risk factors in outpatients with bipolar disorder
    Klumpers, UMH
    Boom, K
    Janssen, FMG
    Tulen, JHM
    Loonen, AJM
    PHARMACOPSYCHIATRY, 2004, 37 (05) : 211 - 216
  • [27] Significance of homocysteine to the cardiovascular risk in bipolar disorder
    Kapczinski, F.
    Chiarani, F.
    Tramontina, J. F.
    Cereser, K. M.
    Stertz, L.
    Gubert, C.
    Vargas, C.
    Sitta, A.
    Wyse, A. T. S.
    BIPOLAR DISORDERS, 2012, 14 : 87 - 87
  • [28] Life Goals Collaborative Care for Patients With Bipolar Disorder and Cardiovascular Disease Risk
    Kilbourne, Amy M.
    Goodrich, David E.
    Lai, Zongshan
    Clogston, Julia
    Waxmonsky, Jeanette
    Bauer, Mark S.
    PSYCHIATRIC SERVICES, 2012, 63 (12) : 1234 - 1238
  • [29] Quality of therapeutic drug and cardiovascular disease risk monitoring in patients with bipolar disorder
    Kilbourne, A. M.
    Post, E. P.
    Bauer, M. S.
    Zeber, J. E.
    Copeland, L. A.
    Good, C. B.
    Pincus, H. A.
    BIPOLAR DISORDERS, 2007, 9 : 59 - 59
  • [30] The risk of developing cardiovascular disease in bipolar disorder. Biological factors and therapy
    Mosolov, Sergey N.
    Fedorova, Elizaveta Yu
    TERAPEVTICHESKII ARKHIV, 2022, 94 (04): : 579 - 583
12345